IMAZIO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 3.250
AS - Asia 2.214
EU - Europa 804
SA - Sud America 493
AF - Africa 57
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.825
Nazione #
US - Stati Uniti d'America 3.171
SG - Singapore 1.076
CN - Cina 434
BR - Brasile 382
IT - Italia 307
VN - Vietnam 216
HK - Hong Kong 169
FR - Francia 107
DE - Germania 106
IN - India 91
RU - Federazione Russa 69
AR - Argentina 46
KR - Corea 46
NL - Olanda 43
BD - Bangladesh 37
CA - Canada 36
FI - Finlandia 32
GB - Regno Unito 27
AT - Austria 25
JP - Giappone 25
EC - Ecuador 24
ID - Indonesia 23
MX - Messico 22
IE - Irlanda 18
ES - Italia 14
PL - Polonia 14
TR - Turchia 14
ZA - Sudafrica 14
PY - Paraguay 11
SE - Svezia 11
CL - Cile 10
IQ - Iraq 10
KE - Kenya 10
PK - Pakistan 10
SA - Arabia Saudita 10
IL - Israele 7
MA - Marocco 7
UZ - Uzbekistan 7
CO - Colombia 6
DO - Repubblica Dominicana 6
GR - Grecia 6
AU - Australia 4
CH - Svizzera 4
DZ - Algeria 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
PH - Filippine 4
TG - Togo 4
UA - Ucraina 4
UY - Uruguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EG - Egitto 3
KZ - Kazakistan 3
LT - Lituania 3
PE - Perù 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DM - Dominica 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
OM - Oman 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
BH - Bahrain 1
BW - Botswana 1
CM - Camerun 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MT - Malta 1
MW - Malawi 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
Totale 6.824
Città #
Council Bluffs 1.140
San Jose 768
Singapore 508
Ashburn 226
Hong Kong 165
Beijing 123
Ho Chi Minh City 87
Los Angeles 70
Dallas 68
Pittsburgh 66
Lauterbourg 64
Mumbai 52
Hanoi 47
Hefei 47
Seoul 46
Santa Clara 45
New York 43
Milan 36
Redondo Beach 31
São Paulo 30
Boardman 29
Buffalo 29
Frankfurt am Main 29
Munich 24
Helsinki 23
Roubaix 22
Tokyo 21
Amsterdam 20
Atlanta 20
Chicago 20
Rome 18
Vienna 18
Dublin 17
Rio de Janeiro 17
Nuremberg 15
Orem 15
Remanzacco 15
Turin 13
Phoenix 12
Trieste 12
Chennai 11
The Dalles 11
Brooklyn 10
Chandler 10
Düsseldorf 10
Montreal 10
Stockholm 10
Bologna 9
Curitiba 9
Da Nang 9
Guayaquil 9
Haiphong 9
Mexico City 9
North Bergen 9
Seattle 9
Udine 9
Warsaw 9
Baoding 8
Changsha 8
Denver 8
Houston 8
Johannesburg 8
Naples 8
San Francisco 8
Shenzhen 8
Suzhou 8
Toronto 8
Buenos Aires 7
Manchester 7
Quito 7
Xi'an 7
Brasília 6
Charlotte 6
Fort Wayne 6
Nairobi 6
Philadelphia 6
Porto Alegre 6
Queens 6
Thái Bình 6
Ankara 5
Athens 5
Bari 5
Boston 5
Chengdu 5
Contagem 5
Fortaleza 5
Guarulhos 5
Hyderabad 5
Hải Dương 5
Jacksonville 5
Mauá 5
Montoro 5
Ogden 5
Riyadh 5
St Petersburg 5
Tashkent 5
Amman 4
Baghdad 4
Biên Hòa 4
Charlottesville 4
Totale 4.470
Nome #
INFLA-score: A new diagnostic paradigm to identify pericarditis 150
Aortic pseudoaneurysm with a fistula between the non-coronary sinus and right atrium: a case report 113
Machine-learning tool for classifying pulmonary hypertension via expert reader-provided CT features: An educational resource for non-dedicated radiologists 106
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging 102
Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review 101
[ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device] 100
Eosinophilic myocarditis: comprehensive update on pathophysiology, diagnosis, prognosis and management 97
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 95
Colchicine for the treatment of the spectrum of cardiovascular diseases: Current evidence and ongoing perspectives 94
New Developments in the Management of Recurrent Pericarditis 92
Leflunomide-induced pulmonary arterial hypertension: Case report and review of literature 92
Management of cardiac sarcoidosis. A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC 90
Colchicine in acute coronary syndromes: the present and the possible future 90
Asymptomatic Chronic Large Pericardial Effusions: To Drain or to Observe? 88
Age-stratified patterns in clinical presentation, treatment and outcomes in acute pericarditis: a retrospective cohort study 86
Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis 82
Distal Reoperations after Repair of Acute Type A Aortic Dissection—Incidence, Causes and Outcomes 81
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 80
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept 80
The 2023 new European guidelines on infective endocarditis: Main novelties and implications for clinical practice 77
The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases 76
Arrhythmic risk in acute myocarditis: Early threats, late events, and clinical uncertainty 75
ANMCO Position paper: Colchicine as a therapeutic agent in coronary syndromes 74
Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on Myocardial and Pericardial Diseases of the Italian Society of Cardiology 73
Duration of Disease and Long-Term Outcomes in Patients With Difficult-To-Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin-1 Agents 72
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases 71
Anakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene 70
Recurrent pericarditis in older adults: Clinical and laboratory features and outcome 69
Autoptic prevalence of pericarditis in coronavirus disease 2019 patients 69
COVID-19 vaccines do not raise myocarditis and pericarditis incidence: Italian Society of Cardiology registry 66
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases 66
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 65
Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology 65
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 65
How to Use Interleukin-1 Antagonists in Patients With Pericarditis 62
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 62
Outcomes of acute pericarditis with an inflammatory phenotype 61
Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion 61
Sudden cardiac death after acute myocarditis with arrhythmic presentation: Hunting for risk predictors - A systematic review and meta-analysis 60
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 60
Advancing our understanding of cardiac tumors 59
Inflammasome and ventricular arrhythmogenesis: Pathogenic interplay and potential targets on the horizon 58
Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension 58
Comparative Efficacy and Safety of Colchicine and Anti–Interleukin- 1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta- Analysis of Randomized Controlled Trials 57
Focus on 2023 ESC guidelines for the management of infective endocarditis: In light of new evidence 56
Should we start using colchicine for secondary prevention of acute and chronic coronary syndromes after 2024 European society of cardiology guidelines? 55
Unveiling the Spectrum of Pericardial Diseases: Insights, Novelties, and Future Directions 54
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade 54
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases 54
Colchicine for prevention of major adverse cardiovascular events: A meta-analysis of randomized clinical trials 53
Risk Stratification of Recurrent Pericarditis: Hype or Hope? 52
Beyond the storm: rethinking recovery in fulminant myocarditis 52
Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology 51
When heart team really counts: Radical excision of intracardiac leiomyomatosis 51
Prevention of pericardial complications after cardiac surgery: Myth or reality? 50
Medical therapy of pericarditis: Tips and tricks for clinical practice 49
Risk of incident pericarditis after coronavirus disease 2019 recovery: a systematic review and meta-analysis 49
Prognostic role of genetic variants in recurrent pericarditis 47
Pericardial constrictive syndromes: a neglected cause of reversible heart failure 46
One stage extraction and reimplantation of ICD/PM in patients with CIED related endocarditis and spondiloscitis due to E. faecalis treated with double beta-lactam combination: ampicillin plus ceftobiprole 44
Scores for Risk Stratification of Pericarditis 41
Myocarditis: an increasing global health challenge! 35
Catheter ablation to prevent malignant ventricular arrhythmias in symptomatic Brugada syndrome: A systematic review and meta-analysis 35
Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion 35
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: A report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology 33
On the Road to Disclose the Pathogenesis of Pericarditis 33
Pericarditis at the crossroads: Unlocking the next wave of therapies 30
Drug-induced pericarditis: a systematic review of all published cases 28
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 27
Efficacy and safety of colchicine for the treatment of myopericarditis 27
Myocarditis and pericarditis in focus: A critical appraisal of the 2025 ESC vs ACC position statements from the Italian society of cardiology working group on cardiomyopathies and pericardial diseases 25
Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis 23
Inflammatory cardiomyopathy: an update for clinicians 23
The 2025 ESC myocarditis and pericarditis guidelines - what clinicians needs to know 23
Triage and management of acute pericarditis 22
Myopericardial Diseases 20
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 19
Colchicine for acute and chronic coronary syndromes 19
Myocarditis and pericarditis exercise recommendations: a critical review of 2023 COCIS recommendations 19
The top ten novelties of the ESC guidelines for the management of myocarditis and pericarditis 19
Change in prevalence of ATTR variants in Italy: Results from a national survey 19
Management of myopericarditis 18
Value of pericardial effusion as imaging biomarker in acute pericarditis, do we need to focus on more appropriate ones? 18
Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case series 17
Dieci quesiti in tema di sarcoidosi cardiaca [Ten questions about cardiac sarcoidosis] 16
Trends in Acute Pericarditis Hospitalizations and Outcomes among the Elderly in the United States, 1999 - 2012 16
The Torino Pericarditis Score: a new-risk stratification tool to predict complicated pericarditis 16
Editorial commentary: Pericardiocentesis: No more a subspecialty technique! 16
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 15
2015 ESC guidelines for the diagnosis and management of pericardial diseases: What should change in our clinical approach? [Linee guida ESC 2015 per la diagnosi e la terapia delle malattie pericardiche: Cosa dovrebbe cambiare nel nostro approccio clinico?] 15
Anticoagulant and anti-thrombotic therapy in acute type B aortic dissection: When real-life scenarios face the shadows of the evidence-based medicine 15
CHAPTER 66: PERICARDIAL DISEASES 15
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists 14
Inflammatory cardiomyopathy: Position paper of the Italian Society of Cardiology Working Group on cardiomyopathies and pericardial diseases in collaboration with the Italian Society of Cardiology Working Group on cardiac magnetic resonance 14
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial 14
Myocarditis and Pericarditis in Focus: A Brief Report Comparing the 2025 ESC Guidelines and Latest ACC Position Papers 14
Coping with recurrent pericarditis: bridging guidelines and clinical practice 14
From Goliath to David: Interventricular fibroma 14
Physical triggers in takotsubo syndrome: a high-risk phenotype? insights from the eVOLUTION registry 14
Transthoracic echocardiography for arrhythmic mitral valve prolapse: Phenotypic characterization as first step 14
Totale 5.131
Categoria #
all - tutte 30.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 0 0 0 1 1
2022/202345 1 0 0 9 7 10 0 3 2 1 9 3
2023/2024134 2 2 33 15 8 7 1 13 7 11 19 16
2024/20251.262 35 67 52 87 67 55 66 73 186 102 219 253
2025/20266.800 244 364 472 447 400 249 254 149 976 1.515 1.449 281
Totale 8.250